DUBLIN, July 22, 2022 /PRNewswire/ — The “Immunoassay Market: Methods and Tendencies, Forecasts by Utility, Know-how, Product, Person and Nation, with Multiplex and Level of Care Market Evaluation, Government Guides, Customized Forecasts and Evaluation” Report has been added to ResearchAndMarkets.com providing.
The workhorse of the diagnostics business is discovering new legs. The pandemic has created a brand new demand for speedy and available diagnostics. The immunoassay is intensifying.
Advances in genetic information are creating new markets for immunoassays. Speedy diagnostics, point-of-care, biomarkers, and client markets are areas of growth, whereas conventional immunoassay maintains a powerful place within the rising scientific diagnostics market.
The report profiles 58 corporations, massive and small, working on this space. This analysis makes you the knowledgeable in your group.
Key Matters Coated:
1 Market Guides
1.1 Immunoassay Market: Strategic Scenario Evaluation and COVID Influence
1.2 Information for Executives, Advertising, Gross sales and Enterprise Growth Personnel
1.3 Information for administration consultants and funding advisers
2 Introduction and market definition
2.1 Immunoassay Market Definition on this Report
2.1.1 Enzyme-based
2.1.2 Immunofluorescence
2.1.3 Chemiluminescence
2.1.4 DNA/NAT
2.1.5 RIA and others
2.1.6 Reagents/Kits, Analyzers, Software program and Providers
2.1.7 Infectious illness
2.1.8 Autoimmune
2.1.9 Endocrinology
2.1.10 Oncology
2.1.11 Cardiology
2.1.12 different specialty
2.2 Market definition
2.2.1 Market sizes
2.2.2 Foreign money
2.2.3 Years
2.3 Methodology
2.3.1 Authors
2.3.2 Sources
2.4 Perspective: Healthcare, the IVD Business, and the COVID-19 Pandemic
2.4.1 World spending on well being care
2.4.2 Expenditure on Diagnostics
2.4.3 Necessary position of insurance coverage for analysis
3 Business Overview
3.1 Business contributors
3.1.1 IVD Supplier
3.1.2 Impartial specialised/esoteric laboratory
3.1.3 Nationwide/regional unbiased laboratory
3.1.4 Impartial laboratory evaluation
3.1.5 Nationwide/regional public laboratory
3.1.6 Hospital laboratory
3.1.7 Medical laboratory
3.1.8 Audit physique
3.2 Scientific Laboratory Market Segments
3.2.1 Conventional market segmentation
3.2.2 Focus and segmentation of the laboratory
3.2.3 Sharing assessments in hospitals
3.2.4 Economies of scale
3.2.5 Hospital versus central laboratory
3.2.6 Medical workplace laboratory
3.2.7 Doctor and POCT
3.3 Immunoassay – Markets and Dialogue
3.3.1 Devices – Genetics adjustments the panorama
3.3.1.1 RIA: a expertise reveals its age
3.3.1.2 Immunoassay versus PCR versus sequencing: a seesaw battle
3.3.1.3 The Sensible Shrinking Instrument – Severe Implications
3.3.1.4 Analysis funding and capital expenditures: grouping of devices
3.3.1.5 Multiplex vs. POC: A Compensation Evaluation
3.3.2 Reagents and kits: genetics adjustments the panorama
3.3.2.1 Bigger check menus are a boon to tools market
3.3.2.2 Medical workplace laboratories: a brand new frontier
3.3.3 Speedy and POCT to threaten instrument markets
3.3.4 OTC and DTC: big market potential
3.3.5 Economies of scale. It’s going away?
3.3.6 Decrease obstacles to entry for devices/analyzers
3.3.7 Acquisition of miniaturization models and expertise
4 market developments
4.1 Components driving development
4.1.1 Diagnostic components
4.1.2 Altering applied sciences encourage early instrument retirement
4.1.3 Extra open client channels
4.1.4 Immunity expertise comes of age
4.2 Components limiting development
4.2.1 Elevated competitors reduces worth
4.2.2 Menace from PCR-based devices
4.2.3 Decrease obstacles to entry
4.2.4 Properly-being has a disadvantage
4.3 Immunoassay Instrumentation
4.3.1 Instrumentation toughness
4.3.2 Lowering Value of Instrument Adjustments Business Construction
4.3.3 Checklist of instrument specs
4.3.4 Immunoassay – CRISPR Diagnostics
5 Current Immunoassay Developments
5.1 Current developments: significance and tips on how to use this part
5.1.1 Significance of those developments
5.1.2 Learn how to use this part
5.2 FDA grants EUA to Xtrava Well being COVID Level-of-Care Antigen Take a look at
5.3 Alamar Biosciences Augments $80 million for immuno-sandwich assay platform
5.4 FDA grants progressive multiplex immunoassay machine
5.5 Quidel and Beckman settle dispute over cardiac immunoassay
5.6 BGI Americas, Advaite varieties SARS-CoV-2 trial partnership
5.7 BioMerieux obtains the CE mark for 3 immunoassays towards dengue
5.8 COVID-19 Portfolio to Speed up House Infectious Illness Testing
5.9 Roche Diagnostics check portfolio growth in 2021
5.10 PerkinElmer Lengthy Time period Outlook
5.11 Quidel updates Outlook for C19 testing
5.12 Dx corporations search multiplex assessments for SARS-CoV-2, influenza
5.13 Becton Dickinson and NAT Diagnostics Acquisition
5.14 New check diagnoses Lyme illness in quarter-hour
5.15 Multiplexed immunoassay system differentiates malaria species
5.16 ERBA Mannheim introduces subsequent technology Nexus drive
5.17 Uman Diagnostics and Bio-Techne Announce Settlement for Neurofilament Mild Assay
5.18 Software program reduces variability in ELISA biomarker assessments
5.19 Arrayit Company Allergy Testing Community Duplicates
6 Key Firm Profiles
6.1 Abbott Diagnostics
6.2 ABC
6.3 Arlington Scientist
6.4 Arrayit Company
6.5 Self-biodiagnosis
6.6 Consciousness expertise
6.7 Beckman Coulter Analysis
6.8 Becton, Dickinson and firm
6.9 Biocartis
6.10 Biomatic
6.11 bioMerieux Analysis
6.12 Bioneer Company
6.13 Bio-Rad Laboratories, Inc.
6.14 BioTek Devices
6.15 Boditech Med, Inc.
6.16 Boster Organic Know-how
6.17 Diamedix (Erba Analysis)
6.18 Diasorin SpA
6.19 Dynex Applied sciences
6.20 Enzo Biochemistry
6.21 Scientific Eurofins
6.22 FUJIFILM Wako Analysis
6.23 Fujirebio
6.24 Gold normal analysis
6.25 Grifols
6.26 Biomedical Hycor
6.27 Immunodiagnostic Techniques (IDS)
6.28 Immunodiagnosis AG
6.29 Inova Diagnostics
6.30 JR Biomedical
6.31 Luminex Corp
6.32 Biomedical maxim
6.33 Mbio Analysis
6.34 Discovery at meso scale
6.35 Millipore Sigma
6.36 Mindray
6.37 Molecular Gadgets
6.38 megapixel biomedical
6.39 MyCartis
6.40 Operon
6.41 Scientific analysis of orthopedics
6.42 Perkin–Elmer
6.43 Qiagen GmbH
6.44 Quidel
6.45 R&D methods
6.46 Random Toxicology
6.47 Roche Molecular Diagnostics
6.48 SD Biosensor
6.49 Serametrix
6.50 Siemens Healthineers
6.51 Sysmex
6.52 tecano
6.53 Thermo Fisher Scientific Inc.
6.54 TOSOH Bioscience
6.55 Veredus Laboratories
6.56 Vircell
6.57 YD Analysis
6.58 Zhejiang Orient Genetic Biotechnology
7 The world market
7.1 World Market by Nation
7.2 World Market by Utility
7.3 World Market by Know-how
7.4 World Market by Product
7.5 World Market by Person
8 World Market by Utility
8.1 Endocrinology purposes
8.2 Immune Functions
8.3 Oncology purposes
8.4 Infectious Illness Functions
8.5 Cardiology purposes
8.6 Different purposes
9 Immunoassay by Know-how
9.1 Enzyme
9.2 Fluorescence
9.3 Chemiluminescence
9.4 Nucleic acid
9.5 Fast/POC
9.6 Different expertise
10 Immunoassay per Product
10.1 Instrument
10.2 Reagents
10.3 Providers
11 Immunoassay per person
11.1 Hospitals
11.2 Outpatient Laboratory
11.3 POC/Different
12 Imaginative and prescient of the Way forward for Immunoassay
13 Appendices
13.1 United States Medicare System: 2021 Laboratory Price Schedule
For extra data on this report, go to https://www.researchandmarkets.com/r/wnx0xr
Media Contact:
Analysis and Markets
laura woodenSenior supervisor
[email protected]
For enterprise hours EST name +1-917-300-0470
For US/Canada name toll free +1-800-526-8630
For GMT enterprise hours name +353-1-416-8900
US Fax: 646-607-1907
Fax (exterior the US): +353-1-481-1716
See unique content material:https://www.prnewswire.com/news-releases/global-immunoassay-market-strategies-trends-forecasts-2022-2027-the-genetic-blizzard-and-the-move-to-point-of-care- driving-dramatic-change-for-traditional-immunoassay-technology-301591725.html
SOURCE Analysis and Markets